Skip to content

The Actual News

Stay informed without the news wearing you out.

Full coverage

The White House withdrew Heidi Overton’s nomination to lead the FDA after she struggled to secure Senate support.

The White House withdrew President Donald Trump’s nominee to lead the Food and Drug Administration, citing a lack of support in Congress. Overton faced questions and opposition from senators over her views on vaccines and other issues, and a committee vote scheduled for Wednesday did not go ahead.

What the reports agree on

  • The White House withdrew Heidi Overton’s nomination to lead the FDA. Axios, The Hill, ABC News, Guardian World and 2 more
  • The Senate health committee had scheduled a vote on Overton’s nomination for Wednesday. Axios, The Hill, CBS News
  • Overton faced concerns from senators about her positions on vaccines. Axios, ABC News, Guardian World, Ars Technica

Where reports differ

  • Axios said the White House withdrew the nomination because Overton lacked enough congressional support; The Hill described the move as coming amid opposition from Senate Republicans. The Hill

Reported by one outlet

  • ABC News said the White House dropped Overton’s nomination on Tuesday, November 17, 2026. ABC News
  • The Hill reported that Republicans held a one-vote majority on the Senate health committee. The Hill
  • Guardian World reported that Overton wrote in a 2023 policy brief that Congress should strictly regulate mifepristone. Guardian World
  • CBS News reported that sources said Sen. Roger Marshall was seeking the FDA commissioner role. CBS News

The original reports

The week's biggest stories, one calm email every Monday.